Shell Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Hold |
5,918
| – | – | ﹤0.01% | 1252 |
|
|
2025
Q1 | $20K | Sell |
5,918
-246
| -4% | -$831 | ﹤0.01% | 1227 |
|
|
2024
Q4 | $46K | Sell |
6,164
-82
| -1% | -$612 | ﹤0.01% | 1190 |
|
|
2024
Q3 | $59K | Buy |
+6,246
| New | +$59K | ﹤0.01% | 1159 |
|
|
2024
Q1 | $50K | Sell |
6,284
-677
| -10% | -$5.39K | ﹤0.01% | 1157 |
|
|
2023
Q4 | $57K | Sell |
6,961
-2,091
| -23% | -$17.1K | ﹤0.01% | 1156 |
|
|
2023
Q3 | $41K | Sell |
9,052
-142
| -2% | -$643 | ﹤0.01% | 1211 |
|
|
2023
Q2 | $65K | Sell |
9,194
-53
| -0.6% | -$375 | ﹤0.01% | 1190 |
|
|
2023
Q1 | $56K | Sell |
9,247
-33
| -0.4% | -$200 | ﹤0.01% | 1173 |
|
|
2022
Q4 | $59K | Sell |
9,280
-1,884
| -17% | -$12K | ﹤0.01% | 1245 |
|
|
2022
Q3 | $107K | Sell |
11,164
-2,924
| -21% | -$28K | ﹤0.01% | 1210 |
|
|
2022
Q2 | $156K | Buy |
14,088
+23
| +0.2% | +$255 | ﹤0.01% | 1179 |
|
|
2022
Q1 | $234K | Sell |
14,065
-2,082
| -13% | -$34.6K | 0.01% | 1133 |
|
|
2021
Q4 | $308K | Buy |
16,147
+78
| +0.5% | +$1.49K | 0.01% | 1099 |
|
|
2021
Q3 | $396K | Sell |
16,069
-690
| -4% | -$17K | 0.01% | 969 |
|
|
2021
Q2 | $436K | Buy |
+16,759
| New | +$436K | 0.01% | 977 |
|
|
2021
Q1 | – | Sell |
-12,574
| Closed | -$583K | – | 1471 |
|
|
2020
Q4 | $583K | Buy |
12,574
+6,291
| +100% | +$292K | 0.01% | 729 |
|
|
2020
Q3 | $207K | Buy |
+6,283
| New | +$207K | ﹤0.01% | 1035 |
|